Navigation Links
Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast
Date:10/17/2007

RICHMOND, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its third quarter 2007 financial results on Wednesday, October 24, 2007 after the market closes. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the company will review the financial results and discuss other business matters.

The conference call dial-in numbers are 877-440-5788 for domestic callers and 719-325-4887 for international callers. The passcode for the call is 4209173. Participants may access the live webcast via a link on the Sangamo BioSciences website in the Investor section http://investor.sangamo.com/index.cfm under "Events and Presentations". For those unable to listen in at the designated time, a conference call replay will be available for one week following the conference call, from approximately 8.00 p.m. ET on October 24, 2007 to October 31, 2007. The conference call replay numbers for domestic and international callers are 888-203-1112 and 719-457-0820, respectively. The conference ID number for the replay is 4209173. The webcast will be available on the Sangamo website for two weeks after the call.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy. Phase 1 clinical trials are o
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , Whether it,s CD packaging, containers or ...dentification) are increasingly finding their way ... objects or goods and identify them automatically ...ad and process the data contained in the label. Sm...n conditions of up to 100 degrees Celsius. But at ...
(Date:11/24/2009)...lso Visit Detroit , (Vocu...nch Ambassador for International Investment, and C..., , ,What: Ambassador Appia is available to meet ...ves adopted by France to further develop the finan... and development., , ,When: Available for Intervie...
(Date:11/24/2009)...e/--TwomoreprestigiousuniversitieshavejoinedBioCar...rssiteforlifescienceprofessionals. ,, Northwest...,joining28othermajorlifesciencetrainingInstitution...nlyforpost-graduatesinthelifesciences.Whiletherear...CareerCenteristheonlyonethatserveslifesciencepost-...
(Date:11/24/2009)...wswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DC...asdaqStockMarketthattradinginthecompany,scommonsto...Ewillbefiledwiththe,SecuritiesandExchangeCommissio...Nasdaq,unlessthecompanyfilesanappealtotheNasdaq,Li...ppeal,which,willstaythesuspensionanddelistingthrou...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...n. 12 Microbia Precision Engineering,Inc. (Microb... joined the,company as Director of North American ...ill be responsible for developing and maintaining ...ips across North America. , "Chuck Walton is a...ional,supplement industries with an exceptional 25...
... Singulex, Inc. today announced that it has close... Ltd. and supported by existing investors includin...g round will support the commercialization of Sing...rt of the financing, Hironori Hozoji, investment o...n the company,s Board of Directors. , , "With the...
...ieved bringing Enerkem one step closer to becoming...ls to commercially use waste, feedstock, , , M...ading advanced biofuels and biochemicals technolog...al-scale plant located in Westbury, Quebec, is ent...s clean conditioned synthesis gas. , Construction ...
Other Biology Technology:Microbia PE Adds Nutritional Ingredient Industry Veteran Charles Walton to Senior Management Team 2Singulex Closes $19 Million Financing Round 2Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase 2Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase 3
(Date:11/25/2009)...tant professors recently received funding from the...earch beneficial to understanding the environment....Blackwood, assistant professor in the Department o...rt two separate research projects. , His first p...nities and Functions from the Leaf to the Landscap...
(Date:11/24/2009)...protein that may help gut bacteria bind to the gas...probiotic producers to identify strains that are l...ics need to interact with cells lining the gut to ...rfaces in the gut they are more likely to stick ar... Nathalie Juge from the Institute of Food Research...
(Date:11/24/2009)...ong held secrets of the earth,s history locked in ... very little information on the environments that ... of years. Now, a team of researchers from nine in... tune of $10 million dollars by the National Scien...ngs literally. These scientists will drill throug...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2Labopharm Enters Into CAD 2425 Million Standby Equity Distribution Agreement 62115 1Labopharm Enters Into CAD 2425 Million Standby Equity Distribution Agreement 62115 2Labopharm Enters Into CAD 2425 Million Standby Equity Distribution Agreement 62115 3Sinovac Establishes Joint Venture to Expand Human Use Vaccine Development and Manufacturing Capabilities 14977 1Sinovac Establishes Joint Venture to Expand Human Use Vaccine Development and Manufacturing Capabilities 14977 2Sinovac Establishes Joint Venture to Expand Human Use Vaccine Development and Manufacturing Capabilities 14977 3Abaxis Inc to Present at the 21st Annual Piper Jaffray Health Care Conference 6535 1
...odels predict will do more harm than simply raise ...ake drastic changes in fragile ecosystems througho...rming trend during the last few decades in the Ant...tions to migrate south and perhaps diminished the ...sive food chain at the bottom of the world. , ...
...cts the bacterial composition of the oral cavity e... high intake is needed to counteract the productio... Lif Holgerson in the dissertation she will defend...litol is a sugar alcohol that is produced by reduc...occurs naturally in fruits and berries, such as pe...
...genic Avian Influenza (HPAI) in the Netherlands is... world. Gert-Jan Boender and colleagues have exami...el which can predict the probability of infection ...,. They also identify high-risk areas in the Nethe...cluding that in these regions an epidemic can only...
Other Biology News:Antarctic warming to reduce animals at base of ecosystem, shift some penguin populations southward 2Xylitol reduces risk of cavities 2
Macrophage Differentiation Kit from 3H Biomedical AB
Frozen Tissue Section Panel - Monkey (Cynomolgus) Normal Tissue, Multi-tissue III from BioChain
Tracker Datamatrix TRxD from Micronic BV
Monocyte Activation Kit from 3H Biomedical AB
Biology Products: